Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223620139> ?p ?o ?g. }
- W4223620139 abstract "Melanoma is a highly aggressive skin cancer with a poor prognosis and mortality. Immune checkpoint blockade (ICB) therapy (e.g., anti-PD-1 therapy) has opened a new horizon in melanoma treatment, but some patients present a non-responsive state. Cancer-associated fibroblasts (CAFs) make up the majority of stromal cells in the tumor microenvironment (TME) and have an important impact on the response to immunotherapy. There is still a lack of identification of CAFs-related predictors for anti-PD-1 therapy, although the establishment of immunotherapy biomarkers is well underway. This study aims to explore the potential CAFs-related gene panel for predicting the response to anti-PD-1 therapy in melanoma patients and elucidating their potential effect on TME.Three gene expression datasets from melanoma patients without anti-PD-1 treatment, in a total of 87 samples, were downloaded from Gene Expression Omnibus (GEO) as the discovery sets (GSE91061) and validation sets (GSE78220 and GSE122220). The CAFs-related module genes were identified from the discovery sets by weighted gene co-expression network analysis (WGCNA). Concurrently, we utilized differential gene analysis on the discovery set to obtain differentially expressed genes (DEGs). Then, CAFs-related key genes were screened with the intersection of CAFs-related module genes and DEGs, succeeded by supervised machine learning-based identification. As a consequence of expression analysis, gene set enrichment analysis, survival analysis, staging analysis, TME analysis, and correlation analysis, the multidimensional systematic characterizations of the key genes were uncovered. The diagnostic performance of the CAFs-related gene panel was assessed by receiver operating characteristic (ROC) curves in the validation sets. Eventually, the CAFs-related gene panel was verified by the expression from the single-cell analysis.The six-gene panel associated with CAFs were finally identified for predicting the response to anti-PD-1 therapy, including CDK14, SYNPO2, TCF4, GJA1, CPXM1, and TFPI. The multigene panel demonstrated excellent combined diagnostic performance with the area under the curve of ROC reaching 90.5 and 75.4% ~100% in the discovery and validation sets, respectively.Confirmed by clinical treatment outcomes, the identified CAFs-related genes can be used as a promising biomarker panel for prediction to anti-PD-1 therapy response, which may serve as new immunotherapeutic targets to improve survival outcomes of melanoma patients." @default.
- W4223620139 created "2022-04-15" @default.
- W4223620139 creator A5003958034 @default.
- W4223620139 creator A5012677271 @default.
- W4223620139 creator A5014681852 @default.
- W4223620139 creator A5015239296 @default.
- W4223620139 creator A5026071162 @default.
- W4223620139 creator A5034995105 @default.
- W4223620139 creator A5047307494 @default.
- W4223620139 creator A5052672374 @default.
- W4223620139 creator A5085619655 @default.
- W4223620139 creator A5087992328 @default.
- W4223620139 date "2022-04-11" @default.
- W4223620139 modified "2023-09-30" @default.
- W4223620139 title "A Cancer Associated Fibroblasts-Related Six-Gene Panel for Anti-PD-1 Therapy in Melanoma Driven by Weighted Correlation Network Analysis and Supervised Machine Learning" @default.
- W4223620139 cites W1224709979 @default.
- W4223620139 cites W1490161904 @default.
- W4223620139 cites W1966327575 @default.
- W4223620139 cites W1967480178 @default.
- W4223620139 cites W1989277387 @default.
- W4223620139 cites W2002609089 @default.
- W4223620139 cites W2006617902 @default.
- W4223620139 cites W2010457001 @default.
- W4223620139 cites W2031409539 @default.
- W4223620139 cites W2039161118 @default.
- W4223620139 cites W2047038212 @default.
- W4223620139 cites W2061346823 @default.
- W4223620139 cites W2073698342 @default.
- W4223620139 cites W2082982834 @default.
- W4223620139 cites W2085625330 @default.
- W4223620139 cites W2100471807 @default.
- W4223620139 cites W2109047523 @default.
- W4223620139 cites W2114104545 @default.
- W4223620139 cites W2114720079 @default.
- W4223620139 cites W2126882378 @default.
- W4223620139 cites W2128035403 @default.
- W4223620139 cites W2135046866 @default.
- W4223620139 cites W2152897456 @default.
- W4223620139 cites W2159482845 @default.
- W4223620139 cites W2166662937 @default.
- W4223620139 cites W2169281418 @default.
- W4223620139 cites W2227347159 @default.
- W4223620139 cites W2299181842 @default.
- W4223620139 cites W2336153715 @default.
- W4223620139 cites W2341128841 @default.
- W4223620139 cites W2478018143 @default.
- W4223620139 cites W2512899508 @default.
- W4223620139 cites W2559382297 @default.
- W4223620139 cites W2560367415 @default.
- W4223620139 cites W2572174216 @default.
- W4223620139 cites W2587816384 @default.
- W4223620139 cites W2592144107 @default.
- W4223620139 cites W2607129810 @default.
- W4223620139 cites W2638401050 @default.
- W4223620139 cites W2757117767 @default.
- W4223620139 cites W2761575992 @default.
- W4223620139 cites W2769591387 @default.
- W4223620139 cites W2791420379 @default.
- W4223620139 cites W2809125618 @default.
- W4223620139 cites W2890270801 @default.
- W4223620139 cites W2890611687 @default.
- W4223620139 cites W2895572113 @default.
- W4223620139 cites W2911197932 @default.
- W4223620139 cites W2911949455 @default.
- W4223620139 cites W2912578916 @default.
- W4223620139 cites W2916860038 @default.
- W4223620139 cites W2918319187 @default.
- W4223620139 cites W2921558231 @default.
- W4223620139 cites W2941384888 @default.
- W4223620139 cites W2944545583 @default.
- W4223620139 cites W2952001873 @default.
- W4223620139 cites W2970504186 @default.
- W4223620139 cites W2982479866 @default.
- W4223620139 cites W2991555977 @default.
- W4223620139 cites W2995513124 @default.
- W4223620139 cites W3011427624 @default.
- W4223620139 cites W3016840787 @default.
- W4223620139 cites W3017286719 @default.
- W4223620139 cites W3023745224 @default.
- W4223620139 cites W3028304854 @default.
- W4223620139 cites W3028409760 @default.
- W4223620139 cites W3044572315 @default.
- W4223620139 cites W3092968949 @default.
- W4223620139 cites W3093845241 @default.
- W4223620139 cites W3093866409 @default.
- W4223620139 cites W3097629227 @default.
- W4223620139 cites W3102147110 @default.
- W4223620139 cites W3103119004 @default.
- W4223620139 cites W3111799242 @default.
- W4223620139 cites W3127284279 @default.
- W4223620139 cites W3164371814 @default.
- W4223620139 cites W3174079058 @default.
- W4223620139 cites W3175752499 @default.
- W4223620139 cites W3177711204 @default.
- W4223620139 cites W3197265554 @default.
- W4223620139 cites W3205475594 @default.
- W4223620139 cites W3210650932 @default.
- W4223620139 cites W4211223138 @default.
- W4223620139 cites W4231254854 @default.
- W4223620139 cites W4253759977 @default.